About Arena Pharmaceuticals
Arena Pharmaceuticals is a company based in San Diego (United States) founded in 1997 was acquired by Pfizer in December 2021. The company has 257 employees.
- Headquarter San Diego, United States
- Employees 257
- Stage Public
- SectorsHealthcare
- Website arenapharm.com
- Social LinkedIn
- Acquired by Pfizer (Dec 2021)
Funding Insights of Arena Pharmaceuticals
- Total Rounds 3
- Last Round Post-IPO β $33M
- First Round $100M
(Jun 2009)
- Investors Count 1
All 3 funding rounds of Arena Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2012 | $33M | Post-IPO | β | β | β |
| Jun 2010 | $35.53M | Post-IPO | β | β | β |
| Jun 2009 | $100M | Post-IPO | β | β |
2 investors in total: 2 institutional.
Investors in Arena Pharmaceuticals
Arena Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pfizer and Deerfield Triarc Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides asset management and investment advisory services. | 1994 | deerfieldcapital.com | Springfield, United States | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | pfizer.com | New York, United States |
Investor details for Arena Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Arena Pharmaceuticals
1483 people are tracked at Arena Pharmaceuticals (767 in leadership, 12 in board & advisors, 704 in team); the tracked headcount is 257.
| Name | Role | Group |
|---|---|---|
Ian C Read | CEO | Leadership |
James Farrelly | VP - R&d Digital Platform Lead | Leadership |
John Harrold | Senior Director Of Pharmacometrics | Leadership |
Tomas Kaplan | Director - Commercial Strategy & Innovation (csi) | Leadership |
Sue Diviney | VP & Office of the Ombuds Lead | Leadership |
Roger Luebbe | Director/controller US Sterile Injectable Network | Leadership |
Andrew Muratore | VP & Assistant General Counsel, Mergers & Acquisitions, And Chief Counsel, Pfizer Ventures | Leadership |
Michael Comeaux | Director Product Integrity Corporate Compliance Global Security | Leadership |
Dave Boyd | Project Director Technology Support | Leadership |
Sriram Krishnaswami | Head, R&d Portfolio And Innovation | Leadership |
Michael Hovanyetz | Senior Director, Commercial Enterprise Solutions | Leadership |
Jon Ross | Director Site Supply Operations, North Creek | Leadership |
Torres Ernesto | Director, Physical Risk Mitigation, Global Security | Leadership |
Angela Wasunna Rwiliriza | Chief Counsel, Corporate Affairs, Policy And Privacy | Leadership |
William McDaniel | Director/team Leader, External Supply - Biotech Emerging Markets | Leadership |
Don Desantis | Director Salesforce Enablement | Leadership |
Luiz Arantes | Vice President U.s. Specialty Care Medical Lead | Leadership |
Veronica Garcia | Director, Business Relationship Manager | Leadership |
Waqas Mahmood | Global Procurement Manager (pakistan And Japan)- Business Engagement Partner & Chief Of Staff | Leadership |
Lidia Fonseca | EVP & Chief Digital & Technology Officer | Leadership |
1463 more people are available in the full profile.
Complete people profiles for Arena Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Arena Pharmaceuticals
5 dated milestones of Arena Pharmaceuticals across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Arena Pharmaceuticals is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $100.0M.
- Funding Latest funding round, Post-IPO, of $33.0M.
- Exit Acquired by Pfizer.
Web traffic of Arena Pharmaceuticals
Websites that share an audience with Arena Pharmaceuticals (arenapharm.com).
Websites whose visitors overlap most with Arena Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| halozyme.com | 100% | 11.6K | #1,481,510 | View details | |
| acadia-pharm.com | 97% | – | – | View details | |
| optimerpharma.com | 94% | – | – | View details | |
| celgene.com | 84% | – | – | View details | |
| affymax.com | 82% | – | – | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 27 similar websites and full traffic analytics for Arena Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Arena Pharmaceuticals
Complete news archive for Arena Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Arena Pharmaceuticals
10 companies that operate in the same segment as Arena Pharmaceuticals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Arena Pharmaceuticals
Arena Pharmaceuticals was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Arena Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Ian C Read is the current CEO of Arena Pharmaceuticals.
Arena Pharmaceuticals has 257 employees.
Annual revenue of Arena Pharmaceuticals is $54K as on Dec 31, 2021.
Arena Pharmaceuticals focused on discovering, developing and commercializing drugs that target G protein-coupled receptors (GPCRs). Its internally discovered drug for chronic weight management, BELVIQ (lorcaserin HCl), was approved by the FDA for adults who are overweight with a comorbidity or obese. Its other clinical-stage oral candidates are: Temanogrel, an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases; Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, including potentially pulmonary arterial hypertension; APD334, a modulator of the S1P1 receptor intended for the treatment of autoimmune diseases; APD371, an agonist of the cannabinoid 2 (CB2) receptor intended for the treatment of pain.
Arena Pharmaceuticals has 2 investors. Key investors include Pfizer, and Deerfield Triarc Capital.
Yes. Arena Pharmaceuticals was acquired by Pfizer in December 2021.

